Akorn Current Ratio 2006-2019 | AKRX

Akorn current ratio from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Akorn Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-03-31 $0.55B $0.17B 3.26
2018-12-31 $0.58B $0.17B 3.42
2018-09-30 $0.67B $0.19B 3.47
2018-06-30 $0.70B $0.18B 3.94
2018-03-31 $0.71B $0.15B 4.64
2017-12-31 $0.73B $0.17B 4.27
2017-09-30 $0.76B $0.18B 4.16
2017-06-30 $0.70B $0.13B 5.46
2017-03-31 $0.74B $0.18B 4.21
2016-12-31 $0.69B $0.18B 3.91
2016-09-30 $0.64B $0.16B 4.14
2016-06-30 $0.59B $0.14B 4.28
2016-03-31 $0.53B $0.20B 2.72
2015-12-31 $0.71B $0.23B 3.06
2015-09-30 $0.70B $0.24B 2.94
2015-06-30 $0.61B $0.20B 3.05
2015-03-31 $0.54B $0.15B 3.54
2014-12-31 $0.48B $0.15B 3.16
2014-09-30 $0.49B $0.13B 3.69
2014-06-30 $0.40B $0.10B 3.83
2014-03-31 $0.19B $0.08B 2.44
2013-12-31 $0.17B $0.06B 2.76
2013-09-30 $0.21B $0.05B 4.60
2013-06-30 $0.19B $0.04B 4.73
2013-03-31 $0.17B $0.04B 4.14
2012-12-31 $0.16B $0.04B 3.67
2012-09-30 $0.14B $0.04B 3.65
2012-06-30 $0.12B $0.03B 4.10
2012-03-31 $0.11B $0.03B 3.61
2011-12-31 $0.16B $0.03B 5.51
2011-09-30 $0.19B $0.02B 9.05
2011-06-30 $0.18B $0.02B 9.96
2011-03-31 $0.08B $0.02B 3.66
2010-12-31 $0.07B $0.02B 3.36
2010-09-30 $0.04B $0.01B 3.80
2010-06-30 $0.03B $0.01B 3.79
2010-03-31 $0.03B $0.02B 1.66
2009-12-31 $0.03B $0.02B 1.20
2009-09-30 $0.03B $0.03B 1.23
2009-06-30 $0.04B $0.03B 1.27
2009-03-31 $0.05B $0.03B 1.54
2008-12-31 $0.04B $0.02B 2.25
2008-09-30 $0.05B $0.03B 1.85
2008-06-30 $0.04B $0.02B 1.96
2008-03-31 $0.05B $0.02B 2.02
2007-12-31 $0.05B $0.02B 2.18
2007-09-30 $0.04B $0.02B 2.44
2007-06-30 $0.03B $0.01B 5.12
2007-03-31 $0.04B $0.01B 4.10
2006-12-31 $0.04B $0.01B 3.87
2006-09-30 $0.04B $0.01B 6.61
2006-06-30 $0.04B $0.01B 6.65
2006-03-31 $0.04B $0.01B 4.62
2005-12-31 $0.02B $0.02B 1.02
2005-09-30 $0.02B $0.01B 2.30
2005-06-30 $0.02B $0.01B 2.24
2005-03-31 $0.02B $0.01B 2.36
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.546B $0.694B
Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. They specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. Akorn markets its products to retail pharmacies, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies. Their strategy is focused on continuing to strengthen our leadership position in the development and marketing of specialized generic and branded pharmaceuticals, over-the-counter (`OTC`) drug products and animal health products.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $37.937B 6.91
Mylan (MYL) United Kingdom $8.902B 3.89
Teva Pharmaceutical Industries (TEVA) Israel $8.338B 3.27
Bausch Health Cos (BHC) Canada $7.741B 5.29
Dr Reddy's Laboratories (RDY) India $6.019B 22.52
Supernus Pharmaceuticals (SUPN) United States $1.573B 15.72
Voyager Therapeutics (VYGR) United States $0.985B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.954B 53.34
Homology Medicines (FIXX) United States $0.834B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.755B 1.13
CymaBay Therapeutics (CBAY) United States $0.451B 0.00
Assembly Biosciences (ASMB) United States $0.383B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.370B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.283B 0.00
Sol-Gel Technologies (SLGL) Israel $0.162B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.131B 0.00
Acasti Pharma (ACST) Canada $0.072B 0.00
Agile Therapeutics (AGRX) United States $0.061B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.054B 0.00
Teligent (TLGT) United States $0.023B 0.00
Evoke Pharma (EVOK) United States $0.014B 0.00
China Pharma Holdings (CPHI) China $0.012B 0.00
Aevi Genomic Medicine (GNMX) United States $0.012B 0.00